Pablo Rebollo

716 total citations
25 papers, 262 citations indexed

About

Pablo Rebollo is a scholar working on Economics and Econometrics, Nephrology and Genetics. According to data from OpenAlex, Pablo Rebollo has authored 25 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Economics and Econometrics, 4 papers in Nephrology and 4 papers in Genetics. Recurrent topics in Pablo Rebollo's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Multiple Sclerosis Research Studies (3 papers). Pablo Rebollo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Neurogenetic and Muscular Disorders Research (4 papers) and Multiple Sclerosis Research Studies (3 papers). Pablo Rebollo collaborates with scholars based in Spain, United Kingdom and Netherlands. Pablo Rebollo's co-authors include F Álvarez-Ude, Jordi Alonso, Montse Ferrer, Carlos G. Forero, Yolanda Pardo, Stefanie Schmidt, Olatz Garín, José M Valderas, Luís Rajmil and Francisco Ortega and has published in prestigious journals such as PLoS ONE, Quality of Life Research and Journal of Alzheimer s Disease.

In The Last Decade

Pablo Rebollo

22 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pablo Rebollo Spain 9 72 62 46 39 36 25 262
Tonya Kara New Zealand 10 168 2.3× 31 0.5× 47 1.0× 11 0.3× 29 0.8× 20 418
Cristina M. Bouissou Soares Brazil 9 150 2.1× 51 0.8× 25 0.5× 11 0.3× 24 0.7× 13 364
John Stathoulis Greece 7 79 1.1× 59 1.0× 38 0.8× 17 0.4× 19 0.5× 15 329
Haute Autorité de Santé France 11 18 0.3× 32 0.5× 26 0.6× 18 0.5× 28 0.8× 22 259
Clara Day United Kingdom 13 181 2.5× 34 0.5× 49 1.1× 18 0.5× 159 4.4× 17 435
F. A. Muthny Germany 8 35 0.5× 62 1.0× 93 2.0× 23 0.6× 18 0.5× 30 291
Katie Wong United Kingdom 10 174 2.4× 25 0.4× 77 1.7× 10 0.3× 54 1.5× 21 439
Sheru Kansal United States 8 150 2.1× 11 0.2× 18 0.4× 26 0.7× 52 1.4× 9 292
Gul Nowshad United States 7 82 1.1× 68 1.1× 69 1.5× 5 0.1× 54 1.5× 10 301
Yu-Yu Tien Taiwan 6 27 0.4× 24 0.4× 120 2.6× 21 0.5× 14 0.4× 10 293

Countries citing papers authored by Pablo Rebollo

Since Specialization
Citations

This map shows the geographic impact of Pablo Rebollo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Rebollo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Rebollo more than expected).

Fields of papers citing papers by Pablo Rebollo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Rebollo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Rebollo. The network helps show where Pablo Rebollo may publish in the future.

Co-authorship network of co-authors of Pablo Rebollo

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Rebollo. A scholar is included among the top collaborators of Pablo Rebollo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Rebollo. Pablo Rebollo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arranz, José Ángel, Cristina Martínez, Lucía Gallego, et al.. (2025). Patterns of treatment in first and subsequent lines in RCC in Spain. A real-world descriptive cross-sectional study. Future Oncology. 21(21). 2767–2774.
2.
Gutiérrez‐Gutiérrez, Gerardo, Javier Sotoca, Ana Núñez Ares, et al.. (2025). Assessing therapeutic decisions in generalized myasthenia gravis: Study protocol. PLoS ONE. 20(4). e0322168–e0322168.
3.
4.
Sepúlveda, María, María Elena Díaz Sánchez, Sabas Boyero, et al.. (2024). Preferences for neuromyelitis optica spectrum disorder treatments: A conjoint analysis with neurologists in Spain. Multiple Sclerosis and Related Disorders. 88. 105732–105732. 1 indexed citations
5.
6.
Cobo‐Calvo, Álvaro, Sabas Boyero, María Sepúlveda, et al.. (2024). Therapeutic inertia in the management of neuromyelitis optica spectrum disorder. Frontiers in Neurology. 15. 1341473–1341473. 3 indexed citations
7.
Fortea, Juan, et al.. (2023). Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer’s Disease. Journal of Alzheimer s Disease. 93(1). 275–282. 8 indexed citations
8.
Vázquez‐Costa, Juan F., Mónica Povedano, Inmaculada Pitarch Castellano, et al.. (2022). Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL Study. Neurology and Therapy. 12(1). 89–105. 6 indexed citations
9.
Castro, Francisco, et al.. (2021). Unmet Needs in the Osteoarthritis Chronic Moderate to Severe Pain Management in Spain: A Real Word Data Study. Rheumatology and Therapy. 8(3). 1113–1127. 9 indexed citations
10.
11.
12.
Martínez‐Ginés, María Luisa, José Manuel García‐Domínguez, Pablo Rebollo, et al.. (2018). Spanish validation of a specific measure to assess work-related problems in people with multiple sclerosis: The Multiple Sclerosis Work Difficulties Questionnaire (MSWDQ-23). Multiple Sclerosis and Related Disorders. 22. 115–119. 13 indexed citations
13.
Schmidt, Stefanie, Olatz Garín, Yolanda Pardo, et al.. (2014). Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments. Quality of Life Research. 23(8). 2169–2181. 55 indexed citations
14.
Espuña‐Pons, Montserrat, et al.. (2014). How can we measure bladder volumes in women with advanced pelvic organ prolapse?. Ultrasound in Obstetrics and Gynecology. 46(2). 233–238. 6 indexed citations
15.
16.
Arenas, María Dolores, et al.. (2008). [Is Cinacalcet a cost-effective treatment in severe secondary hyperparathyroidism in patients on hemodialysis?].. PubMed. 28(5). 511–6. 8 indexed citations
17.
Moran, Nicholas, et al.. (2007). Erythropoietin Safety and Efficacy in Chronic Allograft Nephropathy. Transplantation Proceedings. 39(7). 2245–2247. 5 indexed citations
18.
Ortega, Teresa, et al.. (2006). Differences in health-related quality of life between elderly and younger patients on hemodialysis. Journal of Nephrology. 19(6). 808–818. 14 indexed citations
19.
Rebollo, Pablo, et al.. (2005). Health-related quality of life during the bereavement period of caregivers of a deceased elderly person. Quality of Life Research. 14(2). 501–509. 12 indexed citations
20.
Álvarez-Ude, F, et al.. (2004). Health-related quality of life of family caregivers of dialysis patients. Journal of Nephrology. 17(6). 841–850. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tonya Kara Breakdown of academic impact, for papers by Cristina M. Bouissou Soares Breakdown of academic impact, for papers by John Stathoulis Breakdown of academic impact, for papers by Haute Autorité de Santé Breakdown of academic impact, for papers by Clara Day Breakdown of academic impact, for papers by F. A. Muthny Breakdown of academic impact, for papers by Katie Wong Breakdown of academic impact, for papers by Sheru Kansal Breakdown of academic impact, for papers by Gul Nowshad Breakdown of academic impact, for papers by Yu-Yu Tien
Rankless by CCL
2026